Albireo Pharma
ALBO
#5670
Rank
NZ$1.59 B
Marketcap
$76.80
Share price
0.00%
Change (1 day)
131.69%
Change (1 year)

Revenue for Albireo Pharma (ALBO)

Revenue in 2022 (TTM): NZ$87.71 Million

According to Albireo Pharma's latest financial reports the company's current revenue (TTM ) is NZ$99.83 Million. In 2021 the company made a revenue of NZ$59.4 Million an increase over the revenue in the year 2020 that were of NZ$11.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Albireo Pharma from 2009 to 2022

2010201320162019$20M$40M$60M$80M$0.1B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2022 (TTM) NZ$87.71 M47.65%
2021 NZ$59.4 M415.96%
2020 NZ$11.51 M-19.52%
2019 NZ$14.3 M-24.67%
2018 NZ$18.99 M1348790.08%
2017 NZ$0 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA